PHARMACY

Trump admin proposes reform to drug rebate system
The Trump Administration's plan is to lower drug costs by targeting backdoor rebates and encouraging direct discounts to patients.
Bartell Drugs urges vaccination as measles outbreak hits Washington
Bartell Drugs is prepared to administer the measles, mumps and rubella vaccine to help stop the spread of measles in Washington state, the company said.

FDA head renews push for generics competition

The FDA is continuing its push to increase development and approval of generics and biosimilars.
Azova, OneOme partner to offer digital health care solutions

Azova and OneOme are partnering to bring the RightMed pharmacogenomics to pharmacists, patients and providers through the Azova platform.
FDA OKs Mylan's Wixela Inhub, the first generic Advair Diskus

Mylan’s generic Advair Diskus is the first generic drug product approved for one of the most commonly prescribed asthma and COPD inhalers.
NACDS’ Anderson applauds NYT column praising pharmacists

The National Association of Chain Drug Stores has issued a letter responding positively to a recent New York Times' article highlighting the role of pharmacists in health care.
FDA approves new Alimta indication

The FDA's approval of Lilly’s Alimta in combination with Merck's Keytruda, and platinum chemotherapy, is a breakthrough for patients with lung cancer.
Mayne Pharma launches Tolsura

Mayne's launch of Tolsura provides a new treatment to fight life-threatening fungal infections.
NASP weighs in on DIR fee reform in comments to CMS

The National Association of Specialty Pharmacy has submitted its comments to the Centers for Medicare and Medicaid Services in response to the agency’s proposed Medicare Part D rule reform.
NACDS promotes 6 staff members to issues-focused roles

The National Association of Chain Drug Stores team members who have been promoted have a combined 40 years of NACDS service and 80 total years of experience in NACDS’ priority issues, the organization said.